進階搜尋


 
系統識別號 U0026-0812200911295943
論文名稱(中文) 人類CD93蛋白的功能分析
論文名稱(英文) Functional analysis of human CD93
校院名稱 成功大學
系所名稱(中) 醫學檢驗生物技術學系碩博士班
系所名稱(英) Department of Medical Laboratory Science and Biotechnology
學年度 93
學期 2
出版年 94
研究生(中文) 蔡珍佩
研究生(英文) June-Pai Tsai
學號 t3692102
學位類別 碩士
語文別 中文
論文頁數 94頁
口試委員 指導教授-吳華林
口試委員-林尊湄
口試委員-施桂月
口試委員-林淑華
中文關鍵字 人類蛋白 
英文關鍵字 CD93 
學科別分類
中文摘要   CD93蛋白是表現在單核球、嗜中性球、血小板、小神經膠質細胞、內皮細胞、早期幹細胞的第一類的細胞表面醣蛋白。人類CD93蛋白具有652個胺基酸,其中包含了碳水化合物辨認區域、五個EGF相似區域、一個黏蛋白相似區以及一個短的細胞內尾端。CD93蛋白原本被推測與促進FcR和補體受器調控的吞噬作用相關,而命名為C1qRp。然而其他的報導認為CD93蛋白在促進吞噬作用的過程中並不需要。因此CD93蛋白的功能目前仍然是有爭議的。另一方面,CD93蛋白亦被認為參與白血球與內皮細胞的相互作用。

  我們從人類組織細胞淋巴癌U937細胞選殖CD93蛋白的基因,並分別將CD93蛋白、刪除碳水化合物辨認區域的CD93蛋白(L)與刪除細胞內尾端的CD93蛋白(C)的基因送至A2058細胞,並挑選CD93基因穩定表現的細胞株來探討其功能。根據細胞螢光的分佈,CD93蛋白表現在細胞膜上,尤其是在微纖毛構造上,而L CD93和C CD93蛋白也有相似的分佈。表現CD93蛋白的A2058細胞,其延展面積會比載體控制細胞大。細胞增生速率在三種細胞皆有明顯增加,從這些結果推測CD93蛋白參與調控細胞生長及細胞延展的機制,而從L CD93的結果可見,碳水化合物辨識區域也參與在這兩個機制當中,作用與CD93相似,也許與其將內部EGF相似區域更裸露出來,刺激細胞生長和延展有關;另外由C CD93的結果可見,細胞內尾端對於細胞延展的促進是必要的,當尾端被刪除時,CD93對細胞延展的促進作用就和對照組無異,而在細胞生長方面,即使刪除了尾端,細胞仍然較對照組生長得快,推測是單獨的EGF相似區域就可以促進細胞生長,或是C CD93的細胞外送或蛋白的結構並不能真切地模擬真實狀況。

  此外,我們也利用人類單核球THP-1細胞株來研究CD93蛋白的功能。當THP-1細胞接受PMA刺激而分化為巨噬細胞時,CD93蛋白的表現會下降。當THP-1細胞過量表現CD93蛋白時,細胞的吞噬作用會被抑制,並且THP-1細胞吸附到內皮細胞的能力也會被抑制。這些結果顯示,CD93蛋白可能調節了單核球的某些功能。




英文摘要  CD93 is a type I cell surface glycoprotein predominantly expressed on myeloid lineage cells, microglia cells, endothelial cells, and early stem cell precursors. Human CD93 consists of 631 amino acids and contains a carbohydrate recognition domain (CRD), five EGF-like domains, a mucin-like region juxtaposed to the transmembrane region, and a short cytoplasmic tail. CD93 was originally named for its suggested participation in the enhancement of FcR and complement receptor (CR1)-mediated phagocytosis. However, other reports suggested that CD93 was not required for enhancing phagocytosis in vitro. The function of CD93 remains controversial. On the other hand, recent reports have described that CD93 might mediate leukocyte – endothelial interactions.

 In this study, we cloned the gene of CD93 from human histiocytic lymphoma U937 cells and investigated the functions of CD93 in A2058 cells, which stably expressed CD93, CRD deleted CD93 (L CD93) and cytoplasmic tail deleted CD93(C CD93). Based on the distribution of the fluorescence, CD93 was expressed at cell membrane, especially localized at microvilli in the transfected cells. L CD93 and C CD93 also exhibited the similar distribution. The CD93-expressed A2058 cells spreading area were larger than vector control cells. The cell proliferation rate was significantly increased in full length CD93 expressed A2058 cells as well as L CD93 and C CD93 A2058 cells. These results suggested that CD93 on cell surface would regulate cell spreading and proliferation in A2058 cells.

 Moreover, the function of CD93 in THP-1 cells was also studied. We used flow cytometry to explore the expression of CD93 in PMA-stimulated THP-1 differentiation, and demonstrated that CD93 expression level was down-regulated by PMA. In THP-1 cells overexpressed CD93, the phagocytosis and adhesion to endothelial cells were suppressed. These results suggested that the expression of CD93 might regulate the functions of monocyte.
論文目次 中文摘要------------------------------------- 1
英文摘要------------------------------------- 3
致謝---------------------------------------- 5
目錄---------------------------------------- 6
圖、表、附錄目錄-------------------------------- 8
縮寫檢索表----------------------------------- 10
儀器---------------------------------------- 12
藥品---------------------------------------- 14
序論---------------------------------------- 18
一、人類CD93 蛋白--------------------------- 18
二、人類CD93 蛋白的結構與功能----------------- 18
三、人類CD93蛋白與Complement component 1的關係----- 19
四、人類CD93 蛋白與人類幹細胞的關係-------------- 19
五、人類CD93 蛋白在老鼠的相似基因表現------------ 20
六、人類CD93 蛋白剔除老鼠------------------- - 20
七、人類CD93 蛋白與淋巴球的關係---------------- 20
八、人類CD93 蛋白C 端與其他蛋白的關係------------ 20
研究動機------------------------------------- 22
實驗方法------------------------------------- 23
一、人類CD93 蛋白-聚合酶連鎖反應---------------- 23
二、質體製備------------------------------- 26
三、構築質體的方法--------------------------- 29
四、細胞培養方法---------------------------- 34
五、DNA轉染系統--------------------------- 38
六、以西方墨點法確認CD93、DL CD93、DC CD93 蛋白
表現----------------------------------
40
七、細胞生長實驗(cell proliferation assay)------------- 45
八、細胞延展實驗(Cell spreading assay)------------- 46
九、流式細胞儀( Flow Cytometer)測定人類CD93 蛋白抗原
之表現--------------------------------
46
十、吞噬能力的測定( Phagocytosis assay)------------- 47
十一、經PMA 分化的轉染後THP-1 細胞黏附能力測定
( Adhesion assay of THP-1)------------------
48
十二、經PMA分化的THP-1 細胞黏附到人類臍帶靜脈內皮細
胞(HUVEC)能力測定( Assay for THP-1 adesion to
HUVEC)-------------------------------
49
實驗結果------------------------------------- 51
討論---------------------------------------- 57
參考文獻------------------------------------- 65
表----------------------------------------- 70
結果圖-------------------------------------- 71
附錄---------------------------------------- 82
自述---------------------------------------- 92
參考文獻 Adams DO, Hamilton TA. The cell biology of macrophage activation.
Annu Rev Immunol. 2:283-318, 1984

Aderem A, Underhill DM. Mechanisms of phagocytosis in macrophages. Annu Rev Immunol. 17:593-623, 1999

Allen LA, Aderem A. Molecular definition of distinct cytoskeletal structures involved in complement- and Fc receptor-mediated phagocytosis in macrophages. J Exp Med. 184:627-37, 1996

Andrews BS, Shadforth M, Cunningham P, Davis JS 4th. Demonstration of a C1q receptor on the surface of human endothelial cells.
J Immunol. 127:1075-80, 1981

Asseffa A, Dickson LA, Mohla S, Bremner TA. Phorbol myristate acetate-differentiated THP-1 cells display increased levels of MHC class I and class II mRNA and interferon-gamma-inducible tumoricidal activity. Oncol Res. 5:11-8, 1993

Bobak DA, Frank MM, Tenner AJ. Characterization of C1q receptor expression on human phagocytic cells: effects of PDBu and fMLP.
J Immunol. 136:4604-10, 1986

Bobak DA, Gaither TA, Frank MM, Tenner AJ. Modulation of FcR function by complement: subcomponent C1q enhances the phagocytosis of IgG-opsonized targets by human monocytes and culture-derived macrophages. J Immunol. 138:1150-6, 1987

Bohlson SS, Zhang M, Ortiz CE, Tenner AJ. CD93 interacts with the PDZ domain-containing adaptor protein GIPC: implications in the modulation of phagocytosis. J Leukoc Biol. 77:80-9, 2005

Bowtell D, Fu P, Simon M, Senior P. Identification of murine homologues of the Drosophila son of sevenless gene: potential activators of ras.
Proc Natl Acad Sci U S A. 89:6511-5, 1992
Bordin S, Kolb WP, Page RC. C1Q receptors on cultured human gingival fibroblasts: analysis of binding properties. J Immunol. 130:1871-5, 1983

Bordin S, Smith M, Ghebrehiwet B, Oda D, Page RC. Smooth muscle and epithelial cells express specific binding sites for the C1q component of complement. Clin Immunol Immunopathol. 63:51-7, 1992

Bretscher A. Purification of an 80,000-dalton protein that is a component of the isolated microvillus cytoskeleton, and its localization in nonmuscle cells. J Cell Biol. 97:425-32, 1983

Brown EJ. Phagocytosis. Bioessays. 17:109-17, 1995

Brozna JP, Carson SD. Monocyte-associated tissue factor is suppressed by phorbol myristate acetate. Blood. 72:456-62, 1988

Caron E, Hall A. Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases. Science. 282:1717-21, 1998

Cox D, Chang P, Zhang Q, Reddy PG, Bokoch GM, Greenberg S. Requirements for both Rac1 and Cdc42 in membrane ruffling and phagocytosis in leukocytes. J Exp Med. 186:1487-94, 1997

Daha MR, Miltenburg AM, Hiemstra PS, Klar-Mohamad N, Van Es LA, Van Hinsbergh VW. The complement subcomponent C1q mediates binding of immune complexes and aggregates to endothelial cells in vitro.
Eur J Immunol. 18:783-7, 1988

Danet GH, Luongo JL, Butler G, Lu MM, Tenner AJ, Simon MC, Bonnet DA. C1qRp defines a new human stem cell population with hematopoietic and hepatic potential. Proc Natl Acad Sci USA. 99:10441-5, 2002

Dean YD, McGreal EP, Gasque P. Endothelial cells, megakaryoblasts, platelets and alveolar epithelial cells express abundant levels of the mouse AA4 antigen, a C-type lectin-like receptor involved in homing activities and innate immune host defense. Eur J Immunol. 31:1370-81, 2001

Hamada A, Greene BM. Clq enhancement of IgG-dependent eosinophil-mediated killing of schistosomula in vitro.
J Immunol. 138:1240-5, 1987

Hart SP, Dougherty GJ, Haslett C, Dransfield I. CD44 regulates phagocytosis of apoptotic neutrophil granulocytes, but not apoptotic lymphocytes, by human macrophages. J Immunol. 159:919-25, 1997

Khosravi-Far R, Solski PA, Clark GJ, Kinch MS, Der CJ. Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation. Mol Cell Biol. 15:6443-53, 1995

Kohro T, Tanaka T, Murakami T, Wada Y, Aburatani H, Hamakubo T, Kodama T. A comparison of differences in the gene expression profiles of phorbol 12-myristate 13-acetate differentiated THP-1 cells and human monocyte-derived macrophage. J Atheroscler Thromb. 11:88-97, 2004

Madaule P, Axel R. A novel ras-related gene family. Cell. 41:31-40, 1985

Malhotra R, Sim RB. Chemical and hydrodynamic characterization of the human leucocyte receptor for complement subcomponent C1q.
Biochem J. 262:625-31, 1989

Massol P, Montcourrier P, Guillemot JC, Chavrier P. Fc receptor-mediated phagocytosis requires CDC42 and Rac1. EMBO J. 17:6219-29, 1998

McGreal EP, Ikewaki N, Akatsu H, Morgan BP, Gasque P. Human C1qRp is identical with CD93 and the mNI-11 antigen but does not bind C1q. J Immunol. 168:5222-32, 2002

McGreal E, Gasque P. Structure-function studies of the receptors for complement C1q. Biochem Soc Trans. 30:1010-4, 2002

Michl J. Receptor mediated endocytosis. Am J Clin Nutr. 33:2462-71, 1980

Nepomuceno RR, Henschen-Edman AH, Burgess WH, Tenner AJ. cDNA cloning and primary structure analysis of C1qR(P), the human C1q/MBL/SPA receptor that mediates enhanced phagocytosis in vitro. Immunity. 6:119-29, 1997

Nepomuceno RR, Tenner AJ. C1qRP, the C1q receptor that enhances phagocytosis, is detected specifically in human cells of myeloid lineage, endothelial cells, and platelets. J Immunol. 160:1929-35, 1998

Newman SL, Mikus LK, Tucci MA. Differential requirements for cellular cytoskeleton in human macrophage complement receptor- and Fc receptor-mediated phagocytosis. J Immunol. 146:967-74, 1991

Norsworthy PJ, Fossati-Jimack L, Cortes-Hernandez J, Taylor PR, Bygrave AE, Thompson RD, Nourshargh S, Walport MJ, Botto M. Murine CD93 (C1qRp) contributes to the removal of apoptotic cells in vivo but is not required for C1q-mediated enhancement of phagocytosis.
J Immunol. 172:3406-14, 2004

Olson MF, Ashworth A, Hall A. An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1. Science. 269:1270-2, 1995

Park M, Tenner AJ. Cell surface expression of C1qRP/CD93 is stabilized by O-glycosylation. J Cell Physiol. 196:512-22,2003

Peerschke EI, Ghebrehiwet B. Human blood platelets possess specific binding sites for C1q. J Immunol. 138:1537- 41, 1987

Ramesh V. Merlin and the ERM proteins in Schwann cells, neurons and growth cones. Nat Rev Neurosci. 5:462-70, 2004

Savill J, Dransfield I, Gregory C, Haslett C. A blast from the past: clearance of apoptotic cells regulates immune responses.
Nat Rev Immunol. 12:965-75, 2002

Skolnik EY, Batzer A, Li N, Lee CH, Lowenstein E, Mohammadi M, Margolis B, Schlessinger J. The function of GRB2 in linking the insulin receptor to Ras signaling pathways. Science. 260:1953-5, 1993

Steinberger P, Szekeres A, Wille S, Stockl J, Selenko N, Prager E, Staffler G, Madic O, Stockinger H, Knapp W. Identification of human CD93 as the phagocytic C1q receptor (C1qRp) by expression cloning.
J Leukoc Biol. 71:133-40, 2002

Takahashi K, Sasaki T, Mammoto A, Takaishi K, Kameyama T, Tsukita S, Takai Y. Direct interaction of the Rho GDP dissociation inhibitor with ezrin/radixin/moesin initiates the activation of the Rho small G protein.
J Biol Chem. 272:23371-5, 1997

Takai Y, Sasaki T, Matozaki T. Small GTP-Binding Proteins.
Phy Rev. 81:154-188, 2001

Tenner AJ. Functional aspects of the C1q receptors.
Behring Inst Mitt. 93:241-53, 1993

Tenner AJ. Membrane receptors for soluble defense collagens.
Curr Opin Immunol. 11:34-41, 1999

Vignery A. Osteoclasts and giant cells: macrophage-macrophage fusion mechanism. Int J Exp Pathol. 81:291-304, 2000

Yamamoto M, Marui N, Sakai T, Morii N, Kozaki S, Ikai K, Imamura S, Narumiya S. ADP-ribosylation of the rhoA gene product by botulinum C3 exoenzyme causes Swiss 3T3 cells to accumulate in the G1 phase of the cell cycle. Oncogene. 8:1449-55, 1993

Young KR Jr, Ambrus JL Jr, Malbran A, Fauci AS, Tenner AJ. Complement subcomponent C1q stimulates Ig production by human B lymphocytes.
J Immunol. 15;146:3356-64, 1991

Zhang M, Bohlson SS, Dy M, Tenner AJ. Modulated interaction of the ERM protein, moesin, with CD93. Immunology. 115:63-73, 2005

Zhang SC, Schultz DR, Ryan US. Receptor-mediated binding of C1q on pulmonary endothelial cells. Tissue Cell. 18:13-8, 1986
論文全文使用權限
  • 同意授權校內瀏覽/列印電子全文服務,於2015-07-06起公開。
  • 同意授權校外瀏覽/列印電子全文服務,於2015-07-06起公開。


  • 如您有疑問,請聯絡圖書館
    聯絡電話:(06)2757575#65773
    聯絡E-mail:etds@email.ncku.edu.tw